Nov 24, 2014

CanSinotech submitted Clinical Trial Application (CTA) of “Diphtheria and Tetanus Toxoids and Component Pertussis Vaccine Adsorbed” to China Food and Drug Administration.

CanSinotech owns effective patents of this vaccine candidate in China.